Growth Metrics

Boston Scientific (BSX) Long-Term Debt Repayments (2016 - 2020)

Boston Scientific's Long-Term Debt Repayments history spans 11 years, with the latest figure at $1.4 billion for Q2 2020.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $1.4 billion in Q2 2020 year-over-year; TTM through Mar 2021 was $1.4 billion, a 200.63% increase, with the full-year FY2020 number at $1.9 billion, changed N/A from a year prior.
  • Long-Term Debt Repayments hit $1.4 billion in Q2 2020 for Boston Scientific, up from $479.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Repayments for BSX hit a ceiling of $1.6 billion in Q3 2017 and a floor of -$1.2 billion in Q4 2017.
  • Historically, Long-Term Debt Repayments has averaged $405.8 million across 4 years, with a median of $335.0 million in 2016.
  • Biggest five-year swings in Long-Term Debt Repayments: tumbled 480.0% in 2017 and later skyrocketed 140.8% in 2018.
  • Tracing BSX's Long-Term Debt Repayments over 4 years: stood at $320.0 million in 2016, then tumbled by 480.0% to -$1.2 billion in 2017, then skyrocketed by 97.29% to -$33.0 million in 2018, then soared by 4463.64% to $1.4 billion in 2020.
  • Business Quant data shows Long-Term Debt Repayments for BSX at $1.4 billion in Q2 2020, $479.0 million in Q1 2020, and -$33.0 million in Q2 2018.